White Papers

    • Date Published
    • June 2015

    NCPDP Recommendations for Improving Prescription Drug Monitoring Programs, Version 2

    This white paper examines the shortfalls of today’s prescription drug monitoring programs intended to reduce fraud and abuse and proposes a new roadmap for PDMP. The recommendations leverage best practices and NCPDP’s existing, widely adopted standards to help states standardize PDMP’s and provide real-time reporting and access to data, giving providers information in a timely manner, across state lines and across pharmacies.

    • Date Published
    • March 2014

    NCPDP Recommendations and Guidance for Standardizing the Dosing Designations on Prescription Container Labels of Oral Liquid Medications

    This paper provides the healthcare industry, in particular the pharmacy sector, with historical and background information on the patient risks associated with the dosing of liquid medications and recommendations to mitigate those risks through best practices in prescription orders, prescription labeling and the provision of dosing devices. Click here to download the resource document, a companion piece to the white paper.

    • Date Published
    • February 2014

    Electronic Signature Guidance

    NCPDP announces the release of version 1.Ø of this document that provides clarification and guidance to the industry for the use of electronic signatures associated with electronic prescriptions, including validation, authentication, and meeting regulatory requirements. This white paper is intended to assist prescribers, pharmacy and third party auditors in validating the available data transmitted and stored using industry approved datasets.

1 2 3 4

For problems with the site please contact us at webmaster@ncpdp.org